US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Belite Bio, Inc.

158.87

-2.1900-1.36%

Post-market: 158.870.00000.00%16:10 EDT

Volume:135.33K

Turnover:21.57M

Market Cap:6.40B

PE:-58.02

High:162.39

Open:162.39

Low:157.77

Close:161.06

52wk High:200.00

52wk Low:62.18

Shares:40.27M

Float Shares:19.38M

Volume Ratio:0.99

T/O Rate:0.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7382

EPS(LYR):-2.3141

ROE:-22.10%

ROA:-15.65%

PB:8.24

PE(LYR):-68.65

Loading ...

Overview Company News Filings

Belite Bio CSO Nathan L. Mata sells shares worth $155,707.57

Belite Bio CSO Nathan L. Mata disposes of shares worth $156,299.79

Belite Bio CSO Nathan L. Mata disposes of $157,037 in common shares

Belite Bio CSO Nathan L. Mata disposes of ADSs worth $157,936.14

Belite Bio CSO Nathan L. Mata disposes of USD 158,424 in shares

Belite Bio to present Phase 3 tinlarebant Stargardt data at Retinal Therapeutics summit

Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit

Belite Bio CSO Nathan L. Mata disposes of shares worth $165,863

Belite Bio to Participate in Four Upcoming Investor Conferences

Belite Bio CMO to present at Deutsche Bank ADR virtual investor conference

Belite Bio Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Belite Bio CSO Nathan L. Mata disposes of shares worth $163,995.76

Belite Bio Starts Rolling Submission of New Drug Application for Eye Treatment

Belite Bio initiates rolling submission of NDA to U.S FDA for tinlarebant

Belite Bio starts FDA rolling NDA submission for tinlarebant in Stargardt disease

Belite Bio Inc - Expects to Complete Nda Rolling Submission in Q2 2026

THOMSON REUTERS

Belite Bio Inc - Tinlarebant Granted Breakthrough Therapy Designation by FDA for Stargardt Disease

THOMSON REUTERS

Belite Bio CSO Nathan L. Mata disposes of shares worth $159,910

Belite Bio CSO Nathan L. Mata disposes of shares worth $158,718.95

Belite Bio director Wan-Shan Chen disposes of US$198,473 common shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BLTE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BLTE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLTE\",,,,,undefined,":{"symbol":"BLTE","market":"US","secType":"STK","nameCN":"Belite Bio, Inc.","latestPrice":158.87,"timestamp":1787601600000,"preClose":161.06,"halted":0,"volume":135333,"hourTrading":{"tag":"盘后","latestPrice":158.87,"preClose":158.87,"latestTime":"16:10 EDT","volume":1738,"amount":276116.06,"timestamp":1787602205175,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.013597417111635401,"floatShares":19382800,"shares":40272144,"eps":-2.738223,"marketStatus":"Post-Mkt","change":-2.19,"latestTime":"08-24 17:17:46 EDT","open":162.385,"high":162.385,"low":157.77,"amount":21569166,"amplitude":0.028654,"askPrice":164.56,"askSize":100,"bidPrice":150,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.738223,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1651204800000,"exchange":"NASDAQ","adjPreClose":161.06,"preHourTrading":{"tag":"盘前","latestPrice":162,"preClose":161.06,"latestTime":"09:29 EDT","volume":184,"amount":30120.92328,"timestamp":1787578170022,"change":0.94,"changeRate":0.005836,"amplitude":0.012418},"postHourTrading":{"tag":"盘后","latestPrice":158.87,"preClose":158.87,"latestTime":"16:10 EDT","volume":1738,"amount":276116.06,"timestamp":1787602205175,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.992308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLTE\",,,,,undefined,":{"symbol":"BLTE","floatShares":19382800,"roa":"-15.65%","roe":"-22.10%","lyrEps":-2.31411,"volumeRatio":0.992308,"shares":40272144,"dividePrice":0,"high":162.385,"amplitude":0.028654,"preClose":161.06,"low":157.77,"week52Low":62.18,"pbRate":"8.24","week52High":200,"institutionHeld":0,"latestPrice":158.87,"committee":-0.818182,"eps":-2.738223,"divideRate":0,"volume":135333,"delay":0,"ttmEps":-2.738223,"open":162.385,"prevYearClose":159.96,"prevWeekClose":161.06,"prevMonthClose":158.61,"prevQuarterClose":153.985,"fiveDayClose":163.21,"twentyDayClose":158.43,"sixtyDayClose":148},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLTE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"BLTE","fiscalQuarterEnding":"2026/06","expectedEps":-0.73,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.7},{"market":"US","date":"2026-05-20","symbol":"BLTE","fiscalQuarterEnding":"2026/03","expectedEps":-0.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1779249600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2026-03-31","symbol":"BLTE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2026-03-02","symbol":"BLTE","fiscalQuarterEnding":"2025/12","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2025-11-10","symbol":"BLTE","fiscalQuarterEnding":"2025/09","expectedEps":-0.53,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLTE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLTE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1769486400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLTE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLTE","date":"2026-08-21","current":-58.490488,"percent":0.425234,"low":-172.368683,"twenty":-88.719196,"median":-57.780936,"eighty":-40.067584,"high":-14.956745,"avg":-63.388459,"sd":26.686739,"marketCap":6521670999},"quantilePoints":[{"date":"2022-04-29","current":-26.398656,"twenty":-21.821892,"median":-14.956745,"eighty":-14.956745,"marketCap":255169407},{"date":"2022-05-06","current":-40.308429,"twenty":-35.871261,"median":-27.657515,"eighty":-17.818469,"marketCap":389621275},{"date":"2022-05-13","current":-35.39991,"twenty":-36.668954,"median":-33.652677,"eighty":-23.826095,"marketCap":342175534},{"date":"2022-05-20","current":-32.621429,"twenty":-36.112759,"median":-33.266295,"eighty":-27.405744,"marketCap":315318733},{"date":"2022-05-27","current":-37.380865,"twenty":-36.745988,"median":-34.47375,"eighty":-30.038223,"marketCap":361323438},{"date":"2022-06-03","current":-38.461385,"twenty":-37.850894,"median":-35.39991,"eighty":-31.787884,"marketCap":371767749},{"date":"2022-06-10","current":-47.620083,"twenty":-38.810445,"median":-36.371275,"eighty":-32.168639,"marketCap":460295722},{"date":"2022-06-17","current":-74.555916,"twenty":-40.580208,"median":-36.768666,"eighty":-32.673126,"marketCap":720657483},{"date":"2022-06-24","current":-88.191056,"twenty":-58.528195,"median":-37.792492,"eighty":-32.879912,"marketCap":852454746},{"date":"2022-07-01","current":-96.963853,"twenty":-72.549235,"median":-38.332752,"eighty":-33.599043,"marketCap":937252607},{"date":"2022-07-08","current":-110.573267,"twenty":-77.365269,"median":-38.679547,"eighty":-33.64195,"marketCap":1068801195},{"date":"2022-07-15","current":-108.232139,"twenty":-87.120826,"median":-39.696266,"eighty":-34.309535,"marketCap":1046171854},{"date":"2022-07-22","current":-102.289276,"twenty":-100.472972,"median":-41.278457,"eighty":-34.967702,"marketCap":988728142},{"date":"2022-07-29","current":-86.441642,"twenty":-100.164252,"median":-58.528195,"eighty":-35.338166,"marketCap":835544908},{"date":"2022-08-05","current":-78.131924,"twenty":-97.591584,"median":-71.520167,"eighty":-35.482236,"marketCap":755223180},{"date":"2022-08-12","current":-87.565462,"twenty":-95.543741,"median":-72.600688,"eighty":-36.079095,"marketCap":736075276},{"date":"2022-08-19","current":-66.768665,"twenty":-93.315811,"median":-74.864636,"eighty":-36.460142,"marketCap":561257398},{"date":"2022-08-26","current":-75.643543,"twenty":-91.390849,"median":-75.643543,"eighty":-36.673454,"marketCap":635859622},{"date":"2022-09-02","current":-101.706101,"twenty":-95.030364,"median":-76.279604,"eighty":-36.757327,"marketCap":854941487},{"date":"2022-09-09","current":-114.249262,"twenty":-100.225996,"median":-76.845232,"eighty":-37.135985,"marketCap":960379296},{"date":"2022-09-16","current":-114.811338,"twenty":-102.848828,"median":-77.205764,"eighty":-37.627841,"marketCap":965104104},{"date":"2022-09-23","current":-109.456828,"twenty":-106.174005,"median":-77.716055,"eighty":-37.836293,"marketCap":920094096},{"date":"2022-09-30","current":-99.250718,"twenty":-106.801736,"median":-79.400575,"eighty":-38.068668,"marketCap":834301538},{"date":"2022-10-07","current":-86.234231,"twenty":-106.278454,"median":-80.156097,"eighty":-38.358478,"marketCap":724884943},{"date":"2022-10-14","current":-82.151787,"twenty":-105.832011,"median":-82.151787,"eighty":-38.461385,"marketCap":690567920},{"date":"2022-10-21","current":-90.139177,"twenty":-105.405334,"median":-84.829042,"eighty":-38.72318,"marketCap":757709921},{"date":"2022-10-28","current":-85.139662,"twenty":-104.55188,"median":-85.169245,"eighty":-39.176175,"marketCap":715684002},{"date":"2022-11-04","current":-81.826375,"twenty":-103.869533,"median":-84.873416,"eighty":-39.562487,"marketCap":687832505},{"date":"2022-11-11","current":-74.19398,"twenty":-102.848828,"median":-83.60135,"eighty":-40.063564,"marketCap":623674592},{"date":"2022-11-18","current":-79.873901,"twenty":-102.088608,"median":-82.403242,"eighty":-40.512263,"marketCap":671420016},{"date":"2022-11-25","current":-95.848682,"twenty":-101.855338,"median":-83.409061,"eighty":-41.152396,"marketCap":805704019},{"date":"2022-12-02","current":-98.570311,"twenty":-101.188152,"median":-84.60717,"eighty":-44.193289,"marketCap":828582034},{"date":"2022-12-09","current":-92.062067,"twenty":-100.28774,"median":-85.184037,"eighty":-51.983328,"marketCap":773873736},{"date":"2022-12-16","current":-89.784182,"twenty":-99.761792,"median":-85.790487,"eighty":-61.824383,"marketCap":754725832},{"date":"2022-12-23","current":-91.38166,"twenty":-98.978555,"median":-86.012359,"eighty":-68.360546,"marketCap":768154233},{"date":"2022-12-30","current":-89.177732,"twenty":-98.392813,"median":-86.135345,"eighty":-70.79982,"marketCap":749628014},{"date":"2023-01-06","current":-88.719196,"twenty":-97.682823,"median":-86.204648,"eighty":-71.005634,"marketCap":745773565},{"date":"2023-01-13","current":-84.31134,"twenty":-97.564491,"median":-86.204648,"eighty":-72.034701,"marketCap":708721128},{"date":"2023-01-20","current":-87.535879,"twenty":-97.44616,"median":-86.234231,"eighty":-72.446328,"marketCap":735826602},{"date":"2023-01-27","current":-88.600865,"twenty":-97.085248,"median":-86.657722,"eighty":-72.590397,"marketCap":744778869},{"date":"2023-02-03","current":-88.674822,"twenty":-96.971566,"median":-87.24005,"eighty":-73.875322,"marketCap":745400554},{"date":"2023-02-10","current":-91.706776,"twenty":-96.947371,"median":-87.335437,"eighty":-74.241312,"marketCap":770887161},{"date":"2023-02-17","current":-93.363716,"twenty":-96.947371,"median":-87.496436,"eighty":-74.253145,"marketCap":784815396},{"date":"2023-02-24","current":-94.192038,"twenty":-97.132581,"median":-87.565462,"eighty":-74.434808,"marketCap":791778270},{"date":"2023-03-03","current":-95.22744,"twenty":-97.363328,"median":-87.632615,"eighty":-74.92638,"marketCap":800481863},{"date":"2023-03-10","current":-94.961194,"twenty":-97.42841,"median":-87.920457,"eighty":-75.189222,"marketCap":798243796},{"date":"2023-03-17","current":-84.222592,"twenty":-97.363328,"median":-87.934805,"eighty":-75.466045,"marketCap":707975105},{"date":"2023-03-24","current":-79.903484,"twenty":-97.132581,"median":-87.713377,"eighty":-75.714542,"marketCap":671668690},{"date":"2023-03-31","current":-88.452654,"twenty":-96.979278,"median":-87.632615,"eighty":-75.840972,"marketCap":743533012},{"date":"2023-04-06","current":-57.292558,"twenty":-96.963853,"median":-87.632615,"eighty":-75.761875,"marketCap":724636269},{"date":"2023-04-13","current":-57.666119,"twenty":-96.947371,"median":-87.572858,"eighty":-75.049868,"marketCap":729361076},{"date":"2023-04-21","current":-58.76284,"twenty":-96.780899,"median":-87.496436,"eighty":-73.875322,"marketCap":743232403},{"date":"2023-04-28","current":-56.892666,"twenty":-96.263671,"median":-87.36502,"eighty":-70.954181,"marketCap":719578441},{"date":"2023-05-04","current":-56.842842,"twenty":-95.967014,"median":-87.328799,"eighty":-59.191996,"marketCap":718948267},{"date":"2023-05-12","current":-53.472161,"twenty":-95.706684,"median":-87.269633,"eighty":-58.621736,"marketCap":676315896},{"date":"2023-05-19","current":-31.356182,"twenty":-95.434521,"median":-86.850673,"eighty":-57.749299,"marketCap":579242744},{"date":"2023-05-26","current":-31.817882,"twenty":-95.280689,"median":-86.441642,"eighty":-56.991071,"marketCap":587771741},{"date":"2023-06-02","current":-23.242075,"twenty":-95.24519,"median":-86.204648,"eighty":-56.754266,"marketCap":429350860},{"date":"2023-06-09","current":-20.2105,"twenty":-95.211949,"median":-86.135345,"eighty":-55.086075,"marketCap":373348574},{"date":"2023-06-16","current":-19.595992,"twenty":-95.109539,"median":-85.997567,"eighty":-51.074789,"marketCap":361996759},{"date":"2023-06-23","current":-16.755597,"twenty":-94.98486,"median":-85.790487,"eighty":-40.900274,"marketCap":309526148},{"date":"2023-06-30","current":-20.388025,"twenty":-94.961194,"median":-85.31716,"eighty":-39.361819,"marketCap":376627987},{"date":"2023-07-07","current":-17.916335,"twenty":-94.961194,"median":-85.169245,"eighty":-38.409932,"marketCap":330968465},{"date":"2023-07-14","current":-17.670532,"twenty":-94.842862,"median":-84.784667,"eighty":-37.258425,"marketCap":326427739},{"date":"2023-07-21","current":-21.739944,"twenty":-94.742281,"median":-84.31134,"eighty":-36.079095,"marketCap":401601979},{"date":"2023-07-28","current":-28.062553,"twenty":-94.677198,"median":-83.409061,"eighty":-34.796165,"marketCap":518399540},{"date":"2023-08-04","current":-29.93339,"twenty":-94.286703,"median":-82.536365,"eighty":-32.904256,"marketCap":552959509},{"date":"2023-08-11","current":-26.995861,"twenty":-94.08554,"median":-81.989081,"eighty":-32.668261,"marketCap":618043247},{"date":"2023-08-18","current":-31.292116,"twenty":-93.502756,"median":-80.702223,"eighty":-32.00793,"marketCap":716401699},{"date":"2023-08-25","current":-37.94065,"twenty":-93.221718,"median":-80.156097,"eighty":-32.083886,"marketCap":868613234},{"date":"2023-09-01","current":-40.854587,"twenty":-92.915312,"median":-79.903484,"eighty":-32.320414,"marketCap":935324909},{"date":"2023-09-08","current":-37.500586,"twenty":-92.465023,"median":-79.844318,"eighty":-32.523965,"marketCap":858538410},{"date":"2023-09-15","current":-37.738458,"twenty":-92.121233,"median":-79.42228,"eighty":-32.656553,"marketCap":863984261},{"date":"2023-09-21","current":-36.644245,"twenty":-91.920069,"median":-79.21615,"eighty":-32.731151,"marketCap":838933346},{"date":"2023-09-29","current":-37.881182,"twenty":-91.707013,"median":-77.967511,"eighty":-32.822322,"marketCap":867251771},{"date":"2023-10-06","current":-35.787904,"twenty":-91.647669,"median":-77.231491,"eighty":-32.885998,"marketCap":819328282},{"date":"2023-10-13","current":-37.952543,"twenty":-91.405326,"median":-77.122689,"eighty":-32.951309,"marketCap":868885527},{"date":"2023-10-20","current":-38.475863,"twenty":-91.369827,"median":-76.767694,"eighty":-33.211951,"marketCap":880866399},{"date":"2023-10-27","current":-45.552567,"twenty":-91.34616,"median":-76.665504,"eighty":-33.405497,"marketCap":1042880466},{"date":"2023-11-03","current":-47.146312,"twenty":-91.286994,"median":-75.916538,"eighty":-33.631223,"marketCap":1079367668},{"date":"2023-11-10","current":-46.38512,"twenty":-91.12133,"median":-75.643543,"eighty":-34.145321,"marketCap":1061940945},{"date":"2023-11-17","current":-32.223509,"twenty":-90.866917,"median":-74.864636,"eighty":-33.631223,"marketCap":1012655993},{"date":"2023-11-24","current":-33.118039,"twenty":-90.577004,"median":-74.253145,"eighty":-33.149655,"marketCap":1040767491},{"date":"2023-12-01","current":-36.94712,"twenty":-90.2723,"median":-72.600688,"eighty":-33.116322,"marketCap":1161100195},{"date":"2023-12-08","current":-37.377453,"twenty":-90.227926,"median":-71.520167,"eighty":-33.118039,"marketCap":1174623824},{"date":"2023-12-15","current":-38.791402,"twenty":-90.192426,"median":-66.768665,"eighty":-33.149655,"marketCap":1219058607},{"date":"2023-12-22","current":-39.344687,"twenty":-90.091844,"median":-58.792369,"eighty":-33.34111,"marketCap":1236446131},{"date":"2023-12-29","current":-40.284393,"twenty":-90.020845,"median":-58.76284,"eighty":-33.557154,"marketCap":1265977322},{"date":"2024-01-05","current":-35.752728,"twenty":-89.949846,"median":-58.606145,"eighty":-33.562423,"marketCap":1123565223},{"date":"2024-01-12","current":-40.179005,"twenty":-89.831515,"median":-58.014771,"eighty":-33.5858,"marketCap":1262665413},{"date":"2024-01-19","current":-40.266828,"twenty":-89.713183,"median":-57.705441,"eighty":-33.620497,"marketCap":1265425337},{"date":"2024-01-26","current":-40.38978,"twenty":-89.571185,"median":-57.15493,"eighty":-33.927117,"marketCap":1269289231},{"date":"2024-02-02","current":-39.616938,"twenty":-89.506103,"median":-56.892666,"eighty":-34.392767,"marketCap":1245001896},{"date":"2024-02-09","current":-40.284393,"twenty":-89.381854,"median":-56.610494,"eighty":-34.634958,"marketCap":1265977322},{"date":"2024-02-16","current":-42.155022,"twenty":-89.204356,"median":-56.244496,"eighty":-34.960534,"marketCap":1324763712},{"date":"2024-02-23","current":-41.004541,"twenty":-89.151107,"median":-53.472161,"eighty":-35.087183,"marketCap":1288608702},{"date":"2024-03-01","current":-40.61812,"twenty":-89.015026,"median":-51.278227,"eighty":-35.130626,"marketCap":1276465035},{"date":"2024-03-08","current":-40.907936,"twenty":-88.890777,"median":-47.620083,"eighty":-35.295508,"marketCap":1285572785},{"date":"2024-03-15","current":-34.84258,"twenty":-88.843445,"median":-46.825184,"eighty":-35.130626,"marketCap":1102140477},{"date":"2024-03-22","current":-40.334824,"twenty":-88.748779,"median":-46.658674,"eighty":-35.295508,"marketCap":1275871163},{"date":"2024-03-28","current":-36.796197,"twenty":-88.748779,"median":-46.38512,"eighty":-35.324053,"marketCap":1163937298},{"date":"2024-04-05","current":-35.92997,"twenty":-88.748779,"median":-45.487152,"eighty":-35.288372,"marketCap":1136536821},{"date":"2024-04-12","current":-36.768551,"twenty":-88.719196,"median":-44.612971,"eighty":-35.324053,"marketCap":1163062815},{"date":"2024-04-19","current":-31.884508,"twenty":-88.689613,"median":-42.871015,"eighty":-35.086181,"marketCap":1008570762},{"date":"2024-04-26","current":-35.017668,"twenty":-88.674822,"median":-42.11111,"eighty":-34.84258,"marketCap":1107678872},{"date":"2024-05-03","current":-37.874372,"twenty":-88.630448,"median":-41.895765,"eighty":-34.876769,"marketCap":1198042148},{"date":"2024-05-10","current":-39.164497,"twenty":-88.600865,"median":-41.759818,"eighty":-35.017668,"marketCap":1238851370},{"date":"2024-05-17","current":-37.888556,"twenty":-88.51892,"median":-41.404135,"eighty":-35.036098,"marketCap":1235470034},{"date":"2024-05-24","current":-40.736634,"twenty":-88.45295,"median":-41.099684,"eighty":-35.086181,"marketCap":1328340163},{"date":"2024-05-31","current":-44.726371,"twenty":-88.45295,"median":-41.320704,"eighty":-35.090188,"marketCap":1458437495},{"date":"2024-06-07","current":-44.287787,"twenty":-88.45295,"median":-41.564237,"eighty":-35.150327,"marketCap":1444136167},{"date":"2024-06-14","current":-45.649223,"twenty":-88.452713,"median":-41.812512,"eighty":-35.26372,"marketCap":1488529872},{"date":"2024-06-21","current":-44.315199,"twenty":-88.452654,"median":-41.90876,"eighty":-35.309781,"marketCap":1445030000},{"date":"2024-06-28","current":-41.738521,"twenty":-88.435082,"median":-42.047795,"eighty":-35.338325,"marketCap":1361009699},{"date":"2024-07-05","current":-41.574052,"twenty":-88.330443,"median":-41.895765,"eighty":-35.352156,"marketCap":1355646701},{"date":"2024-07-12","current":-44.918251,"twenty":-88.189315,"median":-42.11111,"eighty":-35.375141,"marketCap":1464694326},{"date":"2024-07-19","current":-45.987298,"twenty":-88.174871,"median":-42.325786,"eighty":-35.420258,"marketCap":1499553812},{"date":"2024-07-26","current":-44.899977,"twenty":-88.109788,"median":-43.584226,"eighty":-35.471595,"marketCap":1464098437},{"date":"2024-08-02","current":-43.520266,"twenty":-88.026956,"median":-43.817224,"eighty":-35.574035,"marketCap":1419108843},{"date":"2024-08-09","current":-42.921494,"twenty":-87.985185,"median":-43.584226,"eighty":-35.680862,"marketCap":1514699523},{"date":"2024-08-16","current":-43.329196,"twenty":-87.937675,"median":-43.549246,"eighty":-35.709608,"marketCap":1529087332},{"date":"2024-08-23","current":-42.427047,"twenty":-87.920457,"median":-43.285824,"eighty":-35.766798,"marketCap":1497250478},{"date":"2024-08-30","current":-42.227533,"twenty":-87.837625,"median":-43.151369,"eighty":-35.840236,"marketCap":1490209636},{"date":"2024-09-06","current":-41.811156,"twenty":-87.704739,"median":-42.818846,"eighty":-35.920981,"marketCap":1475515703},{"date":"2024-09-13","current":-42.348976,"twenty":-87.655158,"median":-42.505117,"eighty":-35.939185,"marketCap":1494495366},{"date":"2024-09-20","current":-42.019345,"twenty":-87.592087,"median":-42.444396,"eighty":-36.002643,"marketCap":1482862669},{"date":"2024-09-27","current":-40.379861,"twenty":-87.577296,"median":-42.418372,"eighty":-36.131858,"marketCap":1425005311},{"date":"2024-10-04","current":-44.231346,"twenty":-87.559545,"median":-42.405361,"eighty":-36.278376,"marketCap":1560924185},{"date":"2024-10-11","current":-47.98741,"twenty":-87.52799,"median":-42.427047,"eighty":-36.500979,"marketCap":1693475699},{"date":"2024-10-18","current":-49.401356,"twenty":-87.4777,"median":-42.496443,"eighty":-36.508509,"marketCap":1743373845},{"date":"2024-10-25","current":-58.032497,"twenty":-87.399798,"median":-42.716197,"eighty":-36.512298,"marketCap":2047966817},{"date":"2024-11-01","current":-60.634851,"twenty":-87.378787,"median":-43.151369,"eighty":-36.539601,"marketCap":2139803894},{"date":"2024-11-08","current":-70.332957,"twenty":-87.33942,"median":-43.285824,"eighty":-36.622431,"marketCap":2482050067},{"date":"2024-11-15","current":-77.408654,"twenty":-87.328799,"median":-43.549246,"eighty":-36.633108,"marketCap":2557117482},{"date":"2024-11-22","current":-74.996937,"twenty":-87.316966,"median":-43.666461,"eighty":-36.650676,"marketCap":2477448806},{"date":"2024-11-29","current":-59.133818,"twenty":-87.269633,"median":-43.967987,"eighty":-36.6764,"marketCap":1953426542},{"date":"2024-12-06","current":-69.51916,"twenty":-87.269633,"median":-44.153275,"eighty":-36.69182,"marketCap":2296495920},{"date":"2024-12-13","current":-58.273826,"twenty":-87.24005,"median":-44.231346,"eighty":-36.709998,"marketCap":1925017556},{"date":"2024-12-20","current":-59.937724,"twenty":-86.853269,"median":-44.309468,"eighty":-36.711971,"marketCap":1979982767},{"date":"2024-12-27","current":-57.956002,"twenty":-86.849115,"median":-44.333473,"eighty":-36.757235,"marketCap":1914518584},{"date":"2025-01-03","current":-58.040132,"twenty":-86.619651,"median":-44.383728,"eighty":-36.76862,"marketCap":1917297723},{"date":"2025-01-10","current":-51.851927,"twenty":-86.457078,"median":-44.443119,"eighty":-36.779678,"marketCap":1712876546},{"date":"2025-01-17","current":-52.54366,"twenty":-86.358678,"median":-44.497942,"eighty":-36.814627,"marketCap":1735727251},{"date":"2025-01-24","current":-55.544285,"twenty":-86.228314,"median":-44.552765,"eighty":-36.851488,"marketCap":1834849907},{"date":"2025-01-31","current":-55.938057,"twenty":-86.204648,"median":-44.601142,"eighty":-36.900103,"marketCap":1847857786},{"date":"2025-02-07","current":-55.446527,"twenty":-86.200593,"median":-44.698959,"eighty":-36.953149,"marketCap":1831620579},{"date":"2025-02-14","current":-53.971937,"twenty":-86.164763,"median":-44.749213,"eighty":-36.980019,"marketCap":1782908960},{"date":"2025-02-21","current":-54.935721,"twenty":-86.086316,"median":-44.854291,"eighty":-36.991032,"marketCap":1814746620},{"date":"2025-02-28","current":-55.128478,"twenty":-86.02715,"median":-44.9548,"eighty":-37.001054,"marketCap":1821114152},{"date":"2025-03-07","current":-60.901548,"twenty":-85.997567,"median":-45.140974,"eighty":-37.048628,"marketCap":2011821735},{"date":"2025-03-14","current":-65.002451,"twenty":-85.849653,"median":-45.320286,"eighty":-37.105201,"marketCap":2147290978},{"date":"2025-03-21","current":-60.090666,"twenty":-85.790487,"median":-45.462383,"eighty":-37.164804,"marketCap":2171917014},{"date":"2025-03-28","current":-59.572643,"twenty":-85.790487,"median":-45.621812,"eighty":-37.191352,"marketCap":2153193592},{"date":"2025-04-04","current":-50.81984,"twenty":-85.31716,"median":-45.720036,"eighty":-37.227032,"marketCap":1836832314},{"date":"2025-04-11","current":-50.551898,"twenty":-85.198828,"median":-45.987298,"eighty":-37.245718,"marketCap":1827147785},{"date":"2025-04-17","current":-50.373269,"twenty":-85.175162,"median":-46.38512,"eighty":-37.351106,"marketCap":1820691433},{"date":"2025-04-25","current":-52.007721,"twenty":-85.145579,"median":-46.700301,"eighty":-37.380183,"marketCap":1879767059},{"date":"2025-05-02","current":-55.964345,"twenty":-84.997664,"median":-46.789503,"eighty":-37.400523,"marketCap":2022775269},{"date":"2025-05-09","current":-54.571041,"twenty":-84.678169,"median":-47.383198,"eighty":-37.411979,"marketCap":1972415719},{"date":"2025-05-16","current":-48.858885,"twenty":-84.512504,"median":-47.693419,"eighty":-37.416587,"marketCap":2078945537},{"date":"2025-05-23","current":-49.033381,"twenty":-84.34684,"median":-48.022108,"eighty":-37.45539,"marketCap":2086370342},{"date":"2025-05-30","current":-50.205396,"twenty":-84.258091,"median":-47.848618,"eighty":-37.472041,"marketCap":2136239621},{"date":"2025-06-06","current":-49.119296,"twenty":-83.849847,"median":-48.100179,"eighty":-37.491071,"marketCap":2090026028},{"date":"2025-06-13","current":-47.528387,"twenty":-83.370603,"median":-47.848618,"eighty":-37.527405,"marketCap":2022332877},{"date":"2025-06-20","current":-46.166937,"twenty":-83.086607,"median":-47.656751,"eighty":-37.54841,"marketCap":1964403162},{"date":"2025-06-27","current":-45.815101,"twenty":-82.749362,"median":-47.146312,"eighty":-37.618944,"marketCap":1949432561},{"date":"2025-07-03","current":-45.482387,"twenty":-82.483116,"median":-47.123012,"eighty":-37.721863,"marketCap":1935275580},{"date":"2025-07-11","current":-47.444253,"twenty":-82.246452,"median":-47.080945,"eighty":-37.741681,"marketCap":2018752951},{"date":"2025-07-18","current":-46.648798,"twenty":-82.086705,"median":-47.138309,"eighty":-37.762158,"marketCap":1984906376},{"date":"2025-07-25","current":-47.306578,"twenty":-81.73171,"median":-47.130661,"eighty":-37.794124,"marketCap":2012894890},{"date":"2025-08-01","current":-49.723535,"twenty":-81.222883,"median":-47.306578,"eighty":-37.81362,"marketCap":2115736407},{"date":"2025-08-08","current":-53.609023,"twenty":-80.631224,"median":-47.45955,"eighty":-37.86727,"marketCap":2281063910},{"date":"2025-08-15","current":-98.849863,"twenty":-82.246452,"median":-47.604873,"eighty":-37.875734,"marketCap":2264848069},{"date":"2025-08-22","current":-93.43304,"twenty":-83.524434,"median":-47.675916,"eighty":-37.881182,"marketCap":2140737810},{"date":"2025-08-29","current":-92.444255,"twenty":-84.583504,"median":-47.98741,"eighty":-37.882657,"marketCap":2118082763},{"date":"2025-09-05","current":-93.347059,"twenty":-85.169245,"median":-48.100179,"eighty":-37.888556,"marketCap":2138767806},{"date":"2025-09-12","current":-98.233664,"twenty":-85.790487,"median":-48.379112,"eighty":-37.928756,"marketCap":2250729707},{"date":"2025-09-19","current":-104.968868,"twenty":-86.086316,"median":-48.559928,"eighty":-37.930737,"marketCap":2405046696},{"date":"2025-09-26","current":-100.325876,"twenty":-86.234231,"median":-48.633609,"eighty":-37.94065,"marketCap":2298666474},{"date":"2025-10-03","current":-106.129616,"twenty":-86.853269,"median":-48.858885,"eighty":-37.946596,"marketCap":2431641752},{"date":"2025-10-10","current":-112.492234,"twenty":-87.328799,"median":-49.053393,"eighty":-37.947556,"marketCap":2577422057},{"date":"2025-10-17","current":-127.639277,"twenty":-87.402756,"median":-49.169943,"eighty":-37.952543,"marketCap":2924471116},{"date":"2025-10-24","current":-132.153297,"twenty":-87.580254,"median":-49.357724,"eighty":-38.059586,"marketCap":3027896332},{"date":"2025-10-31","current":-140.579466,"twenty":-87.920457,"median":-49.578211,"eighty":-38.141512,"marketCap":3220956736},{"date":"2025-11-07","current":-170.145357,"twenty":-88.038789,"median":-49.668864,"eighty":-38.204118,"marketCap":3898370424},{"date":"2025-11-14","current":-62.867205,"twenty":-88.038789,"median":-49.731183,"eighty":-38.297458,"marketCap":3922096298},{"date":"2025-11-21","current":-61.060772,"twenty":-88.009206,"median":-50.085297,"eighty":-38.41346,"marketCap":3809398397},{"date":"2025-11-28","current":-76.865658,"twenty":-87.961164,"median":-50.263812,"eighty":-38.4518,"marketCap":4795417803},{"date":"2025-12-05","current":-84.600321,"twenty":-87.926196,"median":-50.551898,"eighty":-38.461385,"marketCap":5277960208},{"date":"2025-12-12","current":-90.342507,"twenty":-87.926196,"median":-50.817083,"eighty":-38.465443,"marketCap":5636198011},{"date":"2025-12-19","current":-92.928189,"twenty":-88.015123,"median":-51.051465,"eighty":-38.473982,"marketCap":5797510920},{"date":"2025-12-26","current":-93.204797,"twenty":-88.188445,"median":-51.319105,"eighty":-38.482999,"marketCap":5814767650},{"date":"2026-01-02","current":-96.18735,"twenty":-88.452654,"median":-51.851927,"eighty":-38.592579,"marketCap":6000840214},{"date":"2026-01-09","current":-98.619695,"twenty":-88.492532,"median":-52.003264,"eighty":-38.766449,"marketCap":6152586893},{"date":"2026-01-16","current":-89.963675,"twenty":-88.657072,"median":-52.141692,"eighty":-38.800184,"marketCap":5612563794},{"date":"2026-01-23","current":-96.121205,"twenty":-88.742862,"median":-52.291271,"eighty":-38.830228,"marketCap":5996713605},{"date":"2026-01-30","current":-101.635321,"twenty":-88.890777,"median":-52.431964,"eighty":-38.899282,"marketCap":6340722762},{"date":"2026-02-06","current":-107.233622,"twenty":-89.435104,"median":-52.54366,"eighty":-38.907249,"marketCap":6689983967},{"date":"2026-02-13","current":-104.996707,"twenty":-89.762354,"median":-53.057446,"eighty":-38.947409,"marketCap":6550429544},{"date":"2026-02-20","current":-108.099525,"twenty":-90.020845,"median":-53.415891,"eighty":-39.081218,"marketCap":6744005035},{"date":"2026-02-27","current":-113.379125,"twenty":-90.301883,"median":-53.490044,"eighty":-39.142694,"marketCap":7073383486},{"date":"2026-03-06","current":-83.414718,"twenty":-90.301883,"median":-53.860643,"eighty":-39.159746,"marketCap":6473899699},{"date":"2026-03-13","current":-85.942588,"twenty":-90.301883,"median":-54.029764,"eighty":-39.164497,"marketCap":6670090218},{"date":"2026-03-20","current":-80.71659,"twenty":-90.227926,"median":-54.39367,"eighty":-39.237054,"marketCap":6264495230},{"date":"2026-03-27","current":-75.617312,"twenty":-90.227926,"median":-54.422556,"eighty":-39.248948,"marketCap":5868735232},{"date":"2026-04-02","current":-84.77675,"twenty":-90.156927,"median":-54.521294,"eighty":-39.325539,"marketCap":6579608310},{"date":"2026-04-10","current":-91.832608,"twenty":-90.227926,"median":-54.671107,"eighty":-39.358393,"marketCap":7127220553},{"date":"2026-04-17","current":-80.113395,"twenty":-90.156927,"median":-54.889943,"eighty":-39.369191,"marketCap":6217680678},{"date":"2026-04-24","current":-83.357468,"twenty":-90.044511,"median":-54.931528,"eighty":-39.392112,"marketCap":6469456422},{"date":"2026-05-01","current":-80.676039,"twenty":-89.975109,"median":-55.06755,"eighty":-39.425484,"marketCap":6261348033},{"date":"2026-05-08","current":-79.074278,"twenty":-89.914746,"median":-55.152573,"eighty":-39.43251,"marketCap":6137033760},{"date":"2026-05-15","current":-76.007615,"twenty":-89.807848,"median":-55.285556,"eighty":-39.439264,"marketCap":5899027002},{"date":"2026-05-22","current":-62.863227,"twenty":-89.696869,"median":-55.406233,"eighty":-39.581741,"marketCap":5674789230},{"date":"2026-05-29","current":-64.497453,"twenty":-89.634027,"median":-55.586966,"eighty":-39.627477,"marketCap":5822314080},{"date":"2026-06-05","current":-62.954744,"twenty":-89.553435,"median":-55.821442,"eighty":-39.671561,"marketCap":5683050621},{"date":"2026-06-12","current":-59.638354,"twenty":-89.500186,"median":-55.960839,"eighty":-39.711902,"marketCap":5383673526},{"date":"2026-06-18","current":-64.645623,"twenty":-89.381854,"median":-56.058531,"eighty":-39.746916,"marketCap":5835689666},{"date":"2026-06-26","current":-65.294955,"twenty":-89.204356,"median":-56.309501,"eighty":-39.794105,"marketCap":5894306206},{"date":"2026-07-02","current":-62.017787,"twenty":-89.151107,"median":-56.525773,"eighty":-39.809559,"marketCap":5598469707},{"date":"2026-07-10","current":-66.781011,"twenty":-89.015026,"median":-56.867754,"eighty":-39.827989,"marketCap":6028455470},{"date":"2026-07-17","current":-65.661022,"twenty":-88.890777,"median":-56.951724,"eighty":-39.913258,"marketCap":5927351773},{"date":"2026-07-24","current":-68.105824,"twenty":-88.843445,"median":-57.102626,"eighty":-39.964717,"marketCap":6148048948},{"date":"2026-07-31","current":-69.692113,"twenty":-88.748779,"median":-57.367059,"eighty":-39.985795,"marketCap":6291246403},{"date":"2026-08-07","current":-70.018958,"twenty":-88.748779,"median":-57.634318,"eighty":-40.038488,"marketCap":6320751373},{"date":"2026-08-14","current":-63.9038,"twenty":-88.748779,"median":-57.738851,"eighty":-40.047271,"marketCap":6541448548},{"date":"2026-08-21","current":-63.710592,"twenty":-88.719196,"median":-57.780936,"eighty":-40.067584,"marketCap":6521670999}],"updateTime":1787578629897},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLTE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633929130","title":"Belite Bio CSO Nathan L. Mata sells shares worth $155,707.57","url":"https://stock-news.laohu8.com/highlight/detail?id=2633929130","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633929130?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:17","pubTimestamp":1778012222,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Scientific Officer Nathan L. Mata reported sales of 1,000 American depositary shares on May 4, 2026 at prices ranging from USD 153.50 to USD 157.49.Holdings fell to 2,666 American depositary shares following transactions.Sales were executed under a Rule 10b5-1 trading plan adopted Dec. 10, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLbscJcv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CSO Nathan L. Mata sells shares worth $155,707.57","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633965717","title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $156,299.79","url":"https://stock-news.laohu8.com/highlight/detail?id=2633965717","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633965717?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:16","pubTimestamp":1777925782,"startTime":"0","endTime":"0","summary":"Belite Bio reported Chief Scientific Officer Nathan L. Mata sold 1,000 American depositary shares on May 1, 2026.Sales priced between USD 153.89 and USD 160, leaving Mata with 3,666 American depositary shares.Transaction executed under a Rule 10b5-1 trading plan adopted Dec. 10, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL22JKNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $156,299.79","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632647565","title":"Belite Bio CSO Nathan L. Mata disposes of $157,037 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647565","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632647565?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:16","pubTimestamp":1777666572,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Scientific Officer Nathan L. Mata sold 1,000 American depositary shares on April 30.Sales were priced at weighted-average prices ranging from USD 155.68 to USD 158.15 per share.Mata held 4,666 American depositary shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL52hJD2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CSO Nathan L. Mata disposes of $157,037 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631290515","title":"Belite Bio CSO Nathan L. Mata disposes of ADSs worth $157,936.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2631290515","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631290515?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:41","pubTimestamp":1777495313,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Scientific Officer Nathan L. Mata sold 1,000 American depositary shares on April 28, 2026.Sales were priced at a weighted average range of USD 154.65 to USD 162.14 per share.Mata held 6,666 American depositary shares following transactions.Transactions were executed under a Rule 10b5-1 trading plan adopted on Dec. 10, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL2px2x0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CSO Nathan L. Mata disposes of ADSs worth $157,936.14","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630310783","title":"Belite Bio CSO Nathan L. Mata disposes of USD 158,424 in shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2630310783","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630310783?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:53","pubTimestamp":1777323193,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Scientific Officer Nathan L. Mata reported sale of 1,000 American depositary shares on April 24, 2026.Sales were executed under a Rule 10b5-1 trading plan adopted Dec. 10, 2025.Disposals were priced at about USD 157.86 to USD 162.53 per share.Mata held 8,666 American depositary shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL4X3HS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Belite Bio CSO Nathan L. Mata disposes of USD 158,424 in shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396944","title":"Belite Bio to present Phase 3 tinlarebant Stargardt data at Retinal Therapeutics summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396944","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396944?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:02","pubTimestamp":1777291330,"startTime":"0","endTime":"0","summary":"Belite Bio to deliver oral presentation at Retinal Therapeutics Innovation Summit on May 1, 2026, in Denver.Talk scheduled for 10:55-11:10 a.m. MDT, highlighting Phase 3 DRAGON topline data for tinlarebant in Stargardt disease type 1.DRAGON results showed 35.7% reduction in atrophic retinal lesion growth rate versus placebo.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL3x1CPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014013.SGD","BLTE","NDAQ","LU0314104364.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","LU2095319765.USD","LU2210150020.SGD","BK4007","IE00BN0W2W23.USD","BK4112","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","BK4588","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396158","title":"Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396158","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396158?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:00","pubTimestamp":1777291200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April  27, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281569/0/en/Belite-Bio-Announces-Oral-Presentation-at-the-Retinal-Therapeutics-Innovation-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","AMDY","BLTE","LU2360106780.USD","BK4529","LU1880398471.USD","LU0823434740.USD","LU2264538146.SGD","LU2931357623.SGD","IE00BMPRXN33.USD","LU2458330243.SGD","LU0979878070.USD","LU0642271901.SGD","LU1316542783.SGD","AMDU","LU0109392836.USD","BK4566","BK4573","LU0823421333.USD","LU1242518857.USD","BK4534","LU1303367103.USD","LU2250418816.HKD","LU0127658192.USD","LU1989764664.SGD","LU1988902786.USD","LU1951198990.SGD","BK4007","BK4512","AMDG","LU0056508442.USD","LU0889565833.HKD","LU1242518931.SGD","LU1861558580.USD","BK4585","LU1951200564.SGD","LU1861559042.SGD","LU0390134368.USD","BK4539","BK4532","IE00BMPRXR70.SGD","LU1880398554.USD","BK4612","BK4139","IE0004445239.USD","LU0198837287.USD","BK4614","AMYY","LU2355687059.USD","BK4605","LU1852331112.SGD","LU0719512351.SGD","AMUU","AMDW","BK4554","LU0274383776.USD","LU0823434583.USD","DAMD","LU1803068979.SGD","LU2098885051.SGD","LU2458330169.SGD","BK4211","LU2860962120.EUR","LU2089985449.USD","LU0823421416.USD","IE00B5949003.HKD","LU0081259029.USD","BK4543","LU1064131342.USD","AMDL","LU1923623000.USD","LU2054465674.USD","AMDD","BK4575","LU0082616367.USD","IE0009356076.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630278238","title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $165,863","url":"https://stock-news.laohu8.com/highlight/detail?id=2630278238","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630278238?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:20","pubTimestamp":1777062050,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Scientific Officer Nathan L. Mata sold 1,000 American depositary shares on April 23.Sales were executed at weighted average prices ranging from USD 164.47 to USD 169.56 per share.Mata beneficially owned 9,666 American depositary shares following transactions.Disposals were made under Rule 10b5-1 trading plan adopted on Dec. 10, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL2B1tHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $165,863","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629839540","title":"Belite Bio to Participate in Four Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2629839540","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629839540?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:00","pubTimestamp":1776945600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April  23, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeti","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/23/3279857/0/en/Belite-Bio-to-Participate-in-Four-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0081259029.USD","LU2931357623.SGD","LU1852331112.SGD","LU1803068979.SGD","AMDU","IE00BMPRXN33.USD","LU0823434740.USD","BK4512","BK4007","LU0198837287.USD","LU1880398554.USD","BK4575","LU0823434583.USD","BK4588","LU0056508442.USD","LU0109392836.USD","LU2098885051.SGD","IE0004445239.USD","IE00BMPRXR70.SGD","LU2054465674.USD","BLTE","BK4141","LU0889565833.HKD","BK4532","DAMD","LU2089985449.USD","LU2250418816.HKD","LU0274383776.USD","LU0719512351.SGD","BK4534","BK4529","LU0390134368.USD","BK4612","LU1303367103.USD","AMDD","AMDY","IE0009356076.USD","LU1064131342.USD","LU0823421333.USD","LU2264538146.SGD","LU1242518857.USD","AMDG","LU1951198990.SGD","BK4543","AMUU","LU2458330243.SGD","BK4573","LU2360106780.USD","LU1923623000.USD","LU0127658192.USD","LU1861559042.SGD","BK4614","LU0979878070.USD","LU1316542783.SGD","AMYY","LU0642271901.SGD","AMDW","AMDL","LU2458330169.SGD","LU2860962120.EUR","LU1861558580.USD","BK4554","BK4605","IE00B5949003.HKD","LU0082616367.USD","LU1989764664.SGD","LU0823421416.USD","LU2355687059.USD","LU1242518931.SGD","LU1988902786.USD","LU1951200564.SGD","BK4585","BK4566","LU1880398471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629049606","title":"Belite Bio CMO to present at Deutsche Bank ADR virtual investor conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2629049606","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629049606?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:36","pubTimestamp":1776861378,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Medical Officer Hendrick Scholl scheduled to present at Deutsche Bank ADR Virtual Investor Conference on April 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL10fdNZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4007","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","LU0314104364.USD","LU2095319765.USD","BK4585","IE00BN0W2V16.EUR","BLTE","LU2210150020.SGD","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629046176","title":"Belite Bio Price Target Maintained With a $200.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629046176","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629046176?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:16","pubTimestamp":1776860160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLTE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2026 08:16 ET (12:16 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629065894","title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $163,995.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2629065894","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629065894?lang=en_us&edition=fundamental","pubTime":"2026-04-22 05:29","pubTimestamp":1776806972,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Scientific Officer Nathan L. Mata sold 1,000 American depositary shares on April 20.Sales were reported at weighted average prices ranging from USD 162.76 to USD 168.35 per share.Mata held 12,666 American depositary shares following the transactions.Transactions were executed under a Rule 10b5-1 trading plan adopted on Dec. 10, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL7sVvdT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $163,995.76","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629063583","title":"Belite Bio Starts Rolling Submission of New Drug Application for Eye Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2629063583","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629063583?lang=en_us&edition=fundamental","pubTime":"2026-04-22 05:00","pubTimestamp":1776805200,"startTime":"0","endTime":"0","summary":"Belite Bio started rolling submission of a New Drug Application to the Food and Drug Administration for its treatment of a rare retinal disorder.The company on Tuesday said it expects to complete the submission in the second quarter. The NDA is for the company's drug tinlarebant, which is designed to treat Stargardt disease type 1, an inherited retinal disorder caused by genetic mutations that often results in legal blindness.The company has completed a Phase 3 trial in adolescent STGD1 subjects. Tinlarebant was previously granted Breakthrough Therapy Designation by the FDA, the company said.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629105043","title":"Belite Bio initiates rolling submission of NDA to U.S FDA for tinlarebant","url":"https://stock-news.laohu8.com/highlight/detail?id=2629105043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629105043?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:09","pubTimestamp":1776802149,"startTime":"0","endTime":"0","summary":"Belite Bio (BLTE) announced that it has initiated a rolling submission of a New Drug Application, NDA, to the U.S. Food and Drug Administration, FD...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/belite-bio-initiates-rolling-submission-of-nda-to-u-s-fda-for-tinlarebant-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/belite-bio-initiates-rolling-submission-of-nda-to-u-s-fda-for-tinlarebant-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLTE","BK4007","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629057257","title":"Belite Bio starts FDA rolling NDA submission for tinlarebant in Stargardt disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2629057257","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629057257?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:00","pubTimestamp":1776801623,"startTime":"0","endTime":"0","summary":"Belite Bio initiated a rolling NDA submission to FDA for tinlarebant to treat Stargardt disease type 1.Rolling filing proceeds under FDA Breakthrough Therapy Designation.Completion of NDA submission targeted for Q2 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL8Lh0X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","LU2210149790.SGD","LU2095319765.USD","BLTE","SG9999014005.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112","SG9999014013.SGD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","SG9999014021.USD","BK4007","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629105761","title":"Belite Bio Inc - Expects to Complete Nda Rolling Submission in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629105761","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629105761?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:00","pubTimestamp":1776801600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUA3L8YTR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629057666","title":"Belite Bio Inc - Tinlarebant Granted Breakthrough Therapy Designation by FDA for Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2629057666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629057666?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:00","pubTimestamp":1776801600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUA3L8YTR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629030775","title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $159,910","url":"https://stock-news.laohu8.com/highlight/detail?id=2629030775","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629030775?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:16","pubTimestamp":1776716172,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Scientific Officer Nathan L. Mata sold 1,000 American depositary shares on April 16, 2026.Sales prices ranged from USD 158.28 to USD 164.12 per share.Mata held 14,666 American depositary shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDLbhCTg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $159,910","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628317249","title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $158,718.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2628317249","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628317249?lang=en_us&edition=fundamental","pubTime":"2026-04-17 04:16","pubTimestamp":1776370571,"startTime":"0","endTime":"0","summary":"Belite Bio Chief Scientific Officer Nathan L. Mata sold 1,000 American depositary shares on April 15, 2026.Sales prices ranged from USD 167.01 to USD 171.19 per share.Mata held 15,666 American depositary shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL30TTDc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CSO Nathan L. Mata disposes of shares worth $158,718.95","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627021463","title":"Belite Bio director Wan-Shan Chen disposes of US$198,473 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627021463","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627021463?lang=en_us&edition=fundamental","pubTime":"2026-04-14 04:16","pubTimestamp":1776111367,"startTime":"0","endTime":"0","summary":"Belite Bio director Wan-Shan Chen sold 1,100 American depositary shares on April 9.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL5RtRZv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio director Wan-Shan Chen disposes of US$198,473 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":128,"code":"91000000","status":"200"}]}}